<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-vaccines-08-00098">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Katano</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kamisako</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Mizusawa</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ka</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ogura</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Suemizu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kawakami</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse</article-title>
  <source>J. Immunol.</source>
  <year>2015</year>
  <volume>194</volume>
  <fpage>3513</fpage>
  <lpage>3525</lpage>
  <pub-id pub-id-type="doi">10.4049/jimmunol.1401323</pub-id>
  <?supplied-pmid 25712215?>
  <pub-id pub-id-type="pmid">25712215</pub-id>
 </element-citation>
</ref>
